BBS2 and chronic obstructive pulmonary disease: According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2025, in the COPD-BBS group, 30% of patients were classified as mild, 55% as moderate, and 15% as severe.